Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hearing Disorders: HELP
Michael R. Hayden
Based on 6 articles published since 2009
(Why 6 articles?)
||||
Expertise Level
The expertise of Michael R. Hayden ranks in the
  • Top 14%
  • ... of 62,471 published authors worldwide on Hearing Disorders
  • ... from 2009 through 2019
  • ... based on contributions to 6 articles on the topic.
Graphical view (beta)
Aliases Hayden, Michael R   ·   Hayden, M R
Work Locations
Details
Most likely:    University of British Columbia      
2017
  • Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada. · Tom Baker Cancer Centre, Calgary, Alberta, Canada. · Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. · Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada. · Audiology and Speech Pathology Department, BC Children's Hospital, Vancouver, British Columbia, Canada. · Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. · Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre - University Health Network and University of Toronto, Toronto, Ontario, Canada. · BC Cancer Agency and University of British Columbia, Vancouver, British Columbia, Canada. · Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada. · University Institute of Clinical Chemistry, Inselspital Bern University Hospital and University of Bern, Bern, Switzerland. · Neuro-Otology Unit, Vancouver General Hospital, Vancouver, British Columbia, Canada. · Department of Medicine, Centre for Heart Lung Innovation, University of British Columbia, Vancouver, British Columbia, Canada. · Translational Laboratory in Genetic Medicine, Agency for Science Technology and Research (A*STAR), Singapore. · Pubmed 28448657
2014
  • 1] Child and Family Research Institute, Vancouver, British Columbia, Canada [2] Division of Translational Therapeutics, Department of Pediatrics, The University of British Columbia, Vancouver, British Columbia, Canada [3] Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada. · 1] Child and Family Research Institute, Vancouver, British Columbia, Canada [2] Division of Translational Therapeutics, Department of Pediatrics, The University of British Columbia, Vancouver, British Columbia, Canada [3] Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada [4] Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, The University of British Columbia, Vancouver, British Columbia, Canada. · Child and Family Research Institute, Vancouver, British Columbia, Canada. · 1] Child and Family Research Institute, Vancouver, British Columbia, Canada [2] Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada [3] Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, The University of British Columbia, Vancouver, British Columbia, Canada. · Department of Pediatrics, Amalia Children's Hospital, Radboud University Medical Centre, Nijmegen, The Netherlands. · Audiology and Speech Pathology Department, British Columbia Children's Hospital, Vancouver, British Columbia, Canada. · 1] Child and Family Research Institute, Vancouver, British Columbia, Canada [2] Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada [3] Department of Pediatrics, Division of Pediatric Hematology/Oncology/Bone Marrow Transplant, British Columbia Children's Hospital, Vancouver, British Columbia, Canada. · Montreal Heart Institute Research Centre and Université de Montreal, Montreal, QC, Canada. · Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, The University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 25141953
  • 1] Child and Family Research Institute, Vancouver, British Columbia, Canada [2] Division of Translational Therapeutics, Department of Pediatrics, The University of British Columbia, Vancouver, British Columbia, Canada [3] Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada. · 1] Child and Family Research Institute, Vancouver, British Columbia, Canada [2] Division of Translational Therapeutics, Department of Pediatrics, The University of British Columbia, Vancouver, British Columbia, Canada [3] Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada [4] Centre for Molecular Medicine and Therapeutics; Department of Medical Genetics, The University of British Columbia, Vancouver, British Columbia, Canada. · 1] Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada [2] Centre for Molecular Medicine and Therapeutics; Department of Medical Genetics, The University of British Columbia, Vancouver, British Columbia, Canada. · 1] Child and Family Research Institute, Vancouver, British Columbia, Canada [2] Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada [3] Centre for Molecular Medicine and Therapeutics; Department of Medical Genetics, The University of British Columbia, Vancouver, British Columbia, Canada. · Department of Pediatrics, Amalia Children's Hospital, Radboud University Medical Centre, Nijmegen, The Netherlands. · 1] Child and Family Research Institute, Vancouver, British Columbia, Canada [2] Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada [3] Division of Pediatric Hematology/Oncology/Bone Marrow Transplant, Department of Pediatrics, BC Children's Hospital, Vancouver, British Columbia, Canada. · Centre for Molecular Medicine and Therapeutics; Department of Medical Genetics, The University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 24755913
  • 1] Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada [2] Department of Pediatrics, Division of Translational Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada [3] Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada. · 1] Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada [2] Department of Pediatrics, Division of Translational Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada [3] Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada [4] Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada. · Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada. · 1] Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada. · Audiology and Speech Pathology Department, British Columbia Children's Hospital, Vancouver, British Columbia, Canada. · 1] Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada [2] Division of Pediatric Hematology/Oncology/Bone Marrow Transplant, Department of Pediatrics, British Columbia Children's Hospital, Vancouver, British Columbia, Canada. · Montreal Heart Institute Research Centre and Université de Montreal, Montreal, Quebec, Canada. · Pubmed 24193170
2013
  • Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 23588304
2009
  • Department of Medical Genetics, University of British Columbia, Centre for Molecular Medicine and Therapeutics, Vancouver, British Columbia, Canada. · Pubmed 19898482
Probable:    British Columbia Children's Hospital      
2017
  • Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada. · Tom Baker Cancer Centre, Calgary, Alberta, Canada. · Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. · Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada. · Audiology and Speech Pathology Department, BC Children's Hospital, Vancouver, British Columbia, Canada. · Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. · Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre - University Health Network and University of Toronto, Toronto, Ontario, Canada. · BC Cancer Agency and University of British Columbia, Vancouver, British Columbia, Canada. · Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada. · University Institute of Clinical Chemistry, Inselspital Bern University Hospital and University of Bern, Bern, Switzerland. · Neuro-Otology Unit, Vancouver General Hospital, Vancouver, British Columbia, Canada. · Department of Medicine, Centre for Heart Lung Innovation, University of British Columbia, Vancouver, British Columbia, Canada. · Translational Laboratory in Genetic Medicine, Agency for Science Technology and Research (A*STAR), Singapore. · Pubmed 28448657
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Michael R. Hayden in 2009-2019 about Hearing Disorders:

  • Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer. 2017
  • Genetic markers of cisplatin-induced hearing loss in children. 2014
  • Response to "evaluation of pharmacogenetic markers to predict the risk of Cisplatin-induced ototoxicity". 2014
  • Role of TPMT and COMT genetic variation in cisplatin-induced ototoxicity. 2014
  • Replication of TPMT and ABCC3 genetic variants highly associated with cisplatin-induced hearing loss in children. 2013
  • Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy. 2009
Show List of Full Article Records
Google Searches

Learn more about Michael R. Hayden using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of British Columbia
British Columbia Children's Hospital
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of British Columbia
2017
  • Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada. · Tom Baker Cancer Centre, Calgary, Alberta, Canada. · Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. · Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada. · Audiology and Speech Pathology Department, BC Children's Hospital, Vancouver, British Columbia, Canada. · Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. · Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre - University Health Network and University of Toronto, Toronto, Ontario, Canada. · BC Cancer Agency and University of British Columbia, Vancouver, British Columbia, Canada. · Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada. · University Institute of Clinical Chemistry, Inselspital Bern University Hospital and University of Bern, Bern, Switzerland. · Neuro-Otology Unit, Vancouver General Hospital, Vancouver, British Columbia, Canada. · Department of Medicine, Centre for Heart Lung Innovation, University of British Columbia, Vancouver, British Columbia, Canada. · Translational Laboratory in Genetic Medicine, Agency for Science Technology and Research (A*STAR), Singapore. · Pubmed 28448657
2014
  • 1] Child and Family Research Institute, Vancouver, British Columbia, Canada [2] Division of Translational Therapeutics, Department of Pediatrics, The University of British Columbia, Vancouver, British Columbia, Canada [3] Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada. · 1] Child and Family Research Institute, Vancouver, British Columbia, Canada [2] Division of Translational Therapeutics, Department of Pediatrics, The University of British Columbia, Vancouver, British Columbia, Canada [3] Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada [4] Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, The University of British Columbia, Vancouver, British Columbia, Canada. · Child and Family Research Institute, Vancouver, British Columbia, Canada. · 1] Child and Family Research Institute, Vancouver, British Columbia, Canada [2] Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada [3] Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, The University of British Columbia, Vancouver, British Columbia, Canada. · Department of Pediatrics, Amalia Children's Hospital, Radboud University Medical Centre, Nijmegen, The Netherlands. · Audiology and Speech Pathology Department, British Columbia Children's Hospital, Vancouver, British Columbia, Canada. · 1] Child and Family Research Institute, Vancouver, British Columbia, Canada [2] Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada [3] Department of Pediatrics, Division of Pediatric Hematology/Oncology/Bone Marrow Transplant, British Columbia Children's Hospital, Vancouver, British Columbia, Canada. · Montreal Heart Institute Research Centre and Université de Montreal, Montreal, QC, Canada. · Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, The University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 25141953
  • 1] Child and Family Research Institute, Vancouver, British Columbia, Canada [2] Division of Translational Therapeutics, Department of Pediatrics, The University of British Columbia, Vancouver, British Columbia, Canada [3] Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada. · 1] Child and Family Research Institute, Vancouver, British Columbia, Canada [2] Division of Translational Therapeutics, Department of Pediatrics, The University of British Columbia, Vancouver, British Columbia, Canada [3] Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada [4] Centre for Molecular Medicine and Therapeutics; Department of Medical Genetics, The University of British Columbia, Vancouver, British Columbia, Canada. · 1] Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada [2] Centre for Molecular Medicine and Therapeutics; Department of Medical Genetics, The University of British Columbia, Vancouver, British Columbia, Canada. · 1] Child and Family Research Institute, Vancouver, British Columbia, Canada [2] Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada [3] Centre for Molecular Medicine and Therapeutics; Department of Medical Genetics, The University of British Columbia, Vancouver, British Columbia, Canada. · Department of Pediatrics, Amalia Children's Hospital, Radboud University Medical Centre, Nijmegen, The Netherlands. · 1] Child and Family Research Institute, Vancouver, British Columbia, Canada [2] Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada [3] Division of Pediatric Hematology/Oncology/Bone Marrow Transplant, Department of Pediatrics, BC Children's Hospital, Vancouver, British Columbia, Canada. · Centre for Molecular Medicine and Therapeutics; Department of Medical Genetics, The University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 24755913
  • 1] Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada [2] Department of Pediatrics, Division of Translational Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada [3] Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada. · 1] Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada [2] Department of Pediatrics, Division of Translational Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada [3] Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada [4] Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada. · Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada. · 1] Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada. · Audiology and Speech Pathology Department, British Columbia Children's Hospital, Vancouver, British Columbia, Canada. · 1] Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada [2] Division of Pediatric Hematology/Oncology/Bone Marrow Transplant, Department of Pediatrics, British Columbia Children's Hospital, Vancouver, British Columbia, Canada. · Montreal Heart Institute Research Centre and Université de Montreal, Montreal, Quebec, Canada. · Pubmed 24193170
2013
  • Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 23588304
2009
  • Department of Medical Genetics, University of British Columbia, Centre for Molecular Medicine and Therapeutics, Vancouver, British Columbia, Canada. · Pubmed 19898482
British Columbia Children's Hospital
2017
  • Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada. · Tom Baker Cancer Centre, Calgary, Alberta, Canada. · Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. · Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada. · Audiology and Speech Pathology Department, BC Children's Hospital, Vancouver, British Columbia, Canada. · Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. · Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre - University Health Network and University of Toronto, Toronto, Ontario, Canada. · BC Cancer Agency and University of British Columbia, Vancouver, British Columbia, Canada. · Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada. · University Institute of Clinical Chemistry, Inselspital Bern University Hospital and University of Bern, Bern, Switzerland. · Neuro-Otology Unit, Vancouver General Hospital, Vancouver, British Columbia, Canada. · Department of Medicine, Centre for Heart Lung Innovation, University of British Columbia, Vancouver, British Columbia, Canada. · Translational Laboratory in Genetic Medicine, Agency for Science Technology and Research (A*STAR), Singapore. · Pubmed 28448657
Yearly article counts 00100310001
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.